Aethlon Medical (AEMD) EBT Margin (2011 - 2023)
Aethlon Medical's (AEMD) quarterly EBT Margin came in at 429.6% in Q1 2023, up 2843361.0% on a YoY basis from N/an in Q1 2022, and up 98.51% quarter-over-quarter from 28863.21% in Q1 2022.
Powered by 
Analysis
Aethlon Medical (AEMD) EBT Margin (2011 - 2023) Analysis & Trends
Aethlon Medical (AEMD) has reported EBT Margin for 13 consecutive years, with 429.6% the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, EBT Margin rose 2843361.0% year-over-year to 429.6%; the trailing twelve-month figure through Mar 2023 stood at 2070.21% (up 147236.0% YoY), and the FY2023 full-year result was 2070.14%, up 147239.0% from the prior year.
- EBT Margin grew to 429.6% in Q1 2023 per AEMD's latest filing, from 28863.21% in the prior quarter.
- Across five years, EBT Margin topped out at 212.0% in Q4 2019 and bottomed at 28863.21% in Q1 2022.
- Historically, EBT Margin has averaged 5701.32% across 5 years, with a median of 1590.23% in 2021.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 2224788 bps in 2022, then jumped 2843361 bps in 2023.
- Over 5 years, EBT Margin stood at 212.0% in 2019, then tumbled by 85 bps to 391.31% in 2020, then plunged by 3674 bps to 14768.63% in 2021, then tumbled by 95 bps to 28863.21% in 2022, then surged by 99 bps to 429.6% in 2023.
- According to Business Quant data, EBT Margin over the past three periods registered 429.6%, 28863.21%, and 14768.63% for Q1 2023, Q1 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 18.32% |
| 10 | Aethlon Medical | 657,845.56 | 657,845.56 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -429.60% |
| Mar 31, 2022 | -28,863.21% |
| Dec 31, 2021 | -14,768.63% |
| Sep 30, 2021 | -1,522.21% |
| Jun 30, 2021 | -1,590.23% |
| Mar 31, 2021 | -6,615.32% |
| Dec 31, 2020 | -391.31% |
| Mar 31, 2020 | -863.54% |
| Dec 31, 2019 | -212.00% |
| Jun 30, 2019 | -5,400.91% |
| Mar 31, 2019 | -2,057.61% |
| Jun 30, 2018 | -770.18% |
| Mar 31, 2018 | -2,450.53% |
| Dec 31, 2017 | -1,630.12% |
| Sep 30, 2016 | -584.16% |
| Jun 30, 2016 | -25,325.11% |
| Mar 31, 2016 | -614.33% |
| Dec 31, 2015 | -409.60% |
| Sep 30, 2015 | -664.45% |
| Jun 30, 2015 | -632.00% |